Onset and duration of action of formoterol and tiotropium in patients with moderate COPD

被引：0
|
作者：
Richter, K
Stenglein, S
Muecke, M
Riedinger, F
Sieder, C
Schmidtmann, S
Harnest, U
Magnussen, H
机构：
[1] Pulm Res Inst, Grosshansdorf, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
[3] Pulmol Praxis, Berlin, Germany
来源：
THORAX | 2003年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [31] Tregs and HLA-DR Expression in Sputum Cells of COPD Patients Treated with Tiotropium and Formoterol
    Holownia, A.
    Wielgat, P.
    Stasiak-Barmuta, A.
    Kwolek, A.
    Jakubow, P.
    Szepiel, P.
    Chyczewska, E.
    Braszko, J. J.
    Mroz, R. M.
    INFLAMMATORY DISORDERS, 2015, 839 : 7 - 12
  • [32] Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD
    Derom, Eric
    Strandgarden, Kerstin
    Schelfhout, Vanessa
    Borgstrom, Lars
    Pauwels, Romain
    RESPIRATORY MEDICINE, 2007, 101 (09) : 1931 - 1941
  • [33] Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study
    Vogelmeier, Claus
    Kardos, Peter
    Harari, Sergio
    Gans, Steven J. M.
    Stenglein, Stephan
    Thirlwell, Jackie
    RESPIRATORY MEDICINE, 2008, 102 (11) : 1511 - 1520
  • [34] DOES ADD-ON EVENING DOSE OF FORMOTEROL IMPROVE LUNG FUNCTION FOR COPD PATIENTS RECEIVING FIXED-DOSE OF TIOTROPIUM AND FORMOTEROL?
    Imran, M.
    Kotwani, A.
    Chhabra, S.
    Vijayan, V.
    VALUE IN HEALTH, 2009, 12 (03) : A120 - A120
  • [35] Tiotropium plus olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema
    Buhl, Roland
    Derom, Eric
    Bjermer, Leif
    Gronke, Lars
    Voss, Florian
    Flezar, Matjaz
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [36] Cost-effectiveness of adding budesonide/formoterol to tiotropium in severe COPD patients in four Nordic countries
    Nielsen, Rune
    Kankaanranta, Hannu
    Bjermer, Leif
    Lange, Peter
    Arnetorp, Sofie
    Hedegaard, Morten
    Stenling, Anna
    Mittmann, Nicole
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [37] RAPID ONSET OF ACTION OF INHALED FORMOTEROL IN ASTHMATIC-PATIENTS
    WEGENER, T
    HEDENSTROM, H
    MELANDER, B
    CHEST, 1992, 102 (02) : 535 - 538
  • [38] Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
    Calverley, Peter M.
    Eriksson, Goran
    Jenkins, Christine R.
    Anzueto, Antonio R.
    Make, Barry J.
    Persson, Anders
    Fageras, Malin
    Postma, Dirkje S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 13 - 25
  • [39] Budesonide/Formoterol Added to Tiotropium Is Well Tolerated and Reduces Risk of Severe Exacerbations in COPD Patients.
    Welte, T.
    Hartman, L.
    Polanowski, T.
    Hernandez, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [40] Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study
    Dal Negro, Roberto Walter
    Turati, Claudio
    Micheletto, Claudio
    Menegoni, Francesco
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (02) : 97 - 105
12345